Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2007-11-01 Capital/Financing Update
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
FORM 424B5
Capital/Financing Update Classification · 95% confidence The document is a Form 424B5 prospectus supplement related to a debt securities offering by Johnson & Johnson, specifically for 5.50% Notes due 2024. It includes detailed information about the offering, underwriting, interest payments, and legal disclaimers. The document also contains financial data such as sales and earnings figures, but these are supplementary to the main purpose of the document, which is to provide information about the capital raising through debt issuance. The presence of registration fee calculations, underwriting discounts, and offering price confirms this is a capital/financing update. It is not an annual report, earnings release, or any other type of report but a financing prospectus supplement. Therefore, the correct classification is Capital/Financing Update (CAP). The document length and detail support a high confidence score.
2007-11-01 English
FORM 424B5
Capital/Financing Update Classification · 100% confidence The document is a Form 424B5 prospectus supplement related to a debt securities offering by Johnson & Johnson. It includes detailed information about the offering of 4.75% Notes due 2019, underwriting details, and financial data such as sales and earnings statements. The presence of a prospectus supplement and registration fee calculation indicates this is a capital raising document. There is no indication that this is an annual or quarterly report, audit report, earnings release, or any other report type. Instead, it is a detailed financing document related to a securities offering, which fits the Capital/Financing Update category.
2007-11-01 English
FREE WRITING PROSPECTUS
Capital/Financing Update Classification · 95% confidence The document is a Free Writing Prospectus (FWP) related to a £500,000,000 bond issuance by Johnson & Johnson, including details such as coupon rate, maturity, redemption options, and settlement date. It references a registration statement filed with the SEC under Rule 433 and provides information about the offering and how to obtain the prospectus. This type of document is an update on the company's capital raising activities and financing terms, not a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is short and focused on the financing terms, consistent with a capital markets update rather than a full report or announcement of a report.
2007-10-30 English
FREE WRITING PROSPECTUS
Capital/Financing Update Classification · 95% confidence The document is a Free Writing Prospectus (FWP) related to a bond offering by Johnson & Johnson, specifying terms of a 4.75% Notes due 2019. It includes details such as issuer, size, maturity, coupon, price, interest payment dates, redemption options, and settlement date. It references a registration statement filed with the SEC under Rule 433 and provides instructions on obtaining the prospectus. This is a capital markets document related to financing activities, specifically a debt issuance. It is not a full financial report, earnings release, or management discussion. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short and focused on the offering terms, not a report publication announcement or regulatory filing. Confidence is high due to clear content and context.
2007-10-30 English
PRELIMINARY PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 95% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(3) related to a securities offering by Johnson & Johnson. It includes detailed information about the notes being offered, underwriting, use of proceeds, and financial data such as sales and earnings. The presence of a prospectus supplement and references to securities offerings indicate this is a capital raising document. It is not an annual or quarterly report, earnings release, or management discussion. The document is a detailed offering prospectus supplement, which fits the category of Capital/Financing Update (CAP).
2007-10-30 English
PRELIMINARY PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 95% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(3) related to a debt securities offering by Johnson & Johnson. It includes detailed information about the notes being offered, underwriting, legal opinions, and financial data such as sales and earnings. The document is a registration and offering prospectus supplement, which is a capital markets financing document. It is not an annual or quarterly report, earnings release, or any other type of regulatory filing related to financial results or governance. The content clearly relates to a capital raising activity through debt issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief summary, supporting a high confidence level.
2007-10-30 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.